Advertisement

Topics

Biocon Ltd Company Profile

02:05 EDT 20th June 2018 | BioPortfolio


News Articles [77 Associated News Articles listed on BioPortfolio]

Biocon's Biosimilar Arm May Raise $500M to Fund Clinical Development

Biotechnology major BioCon is likely to take its group entity Biocon Biologics public and is expected to raise about $500M.

Mylan and Biocon biosimilar approval expands to Brazil

Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in the global market to make up for time lost due to manufacturing issues. It has...

FDA Approves Mylan and Biocon’s Fulphila, the First Biosimilar to Neulasta

HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, June 4, 2018/PRNewswire/ — Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U....

Biocon down 5% on manufacturing woes

Indian drugmaker Biocon closed more than 5% down at 628.65 rupees after trading on Mumbai on Thursday.

Biocon says FDA 483 at Malaysian plant not due to non-compliance

A US FDA pre-approval inspection of Bioconâs insulin manufacturing facility in Malaysia has resulted in a Form 483 with six observations.

Mylan, Biocon Receive MAA

Mylan and Biocon announced that their co-developed biosimilar insulin glargine Semglee has received marketing authorization approval from the European Commission following the positive recommendation ...

Biocon and Sandoz strike biosimilars partnership

Biosimilars firms Biocon and Sandoz have formed a worldwide partnership to develop the next generation of biosimilars in immunology and cancer. Biocon already has a long-standing partnership with Myl...

Novartis looks to next decade with Biocon biosimilar pact

Novartis and Biocon have teamed up to replenish their pipelines through the development and manufacture of third wave biosimilars.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Biocon Limited

Established in 1978, Biocon Limited is India's largest biotechnology Company by revenue. The Group, promoted by Ms. Kiran Mazumdar-Shaw, is a fully-integrated, innovation-driven h...

BioCon Valley® GmbH

Born out of Germany´s "BioRegio" competition in 1996 BioCon Valley represents an interdisciplinary network in the field of modern life sciences and health care.Universities, research and health care ...

Biocon

Biocon is India's leading biotechnology enterprise. Over the past 25 years, we have evolved from an enzyme manufacturing company to a fully integrated biopharmaceutical enterprise, focused on healthca...

BIOCON, INC.

Since 1978 BIOCON has provided highly reliable, custom small animal research services to the region’s leading biomedical scientists. Whether your study involves small animal housing, breeding and co...

Biocon Ltd

More Information about "Biocon Ltd" on BioPortfolio

We have published hundreds of Biocon Ltd news stories on BioPortfolio along with dozens of Biocon Ltd Clinical Trials and PubMed Articles about Biocon Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biocon Ltd Companies in our database. You can also find out about relevant Biocon Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record